Fusion protein technologies for biopharmaceuticals : applications and challenges /

Mostrar otras versiones (1)

The state of the art in biopharmaceutical FUSION PROTEIN DESIGN Fusion proteins belong to the most lucrative biotech drugs-with Enbrel® being one of the best-selling biologics worldwide. Enbrel® represents a milestone of modern therapies just as Humulin®, the first therapeutic recombinant protein fo...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Schmidt, Stefan R.
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Hoboken, New Jersey : John Wiley & Sons, ©2013.
Temas:
Biopharmaceutics.
Pharmaceutical biotechnology.
Drug carriers (Pharmacy)
Protein engineering.
Recombinant proteins.
Recombinant Fusion Proteins > therapeutic use
Drug Carriers
Immunotoxins > pharmacokinetics
Immunotoxins > therapeutic use
Protein Engineering
Recombinant Fusion Proteins > pharmacokinetics
Biopharmaceutics
Pharmaceutical Vehicles
Recombinant Proteins
Protéines recombinantes.
Biopharmacie.
Biotechnologie pharmaceutique.
Vecteurs de médicaments.
Technologie des protéines.
MEDICAL > Pharmacology.
Recombinant proteins
Protein engineering
Pharmaceutical biotechnology
Internet Resources.
Acceso en línea:Texto completo

Internet

Texto completo

Items no disponibles

Detalle de Existencias desde

Ejemplares similares